Mangoceuticals, Inc. (MGRX) Stock

Healthcare · Health Information Services · Member of Other US Stocks

Mangoceuticals, Inc. (MGRX) closed at USD 0.33 on 2026-10-14, a change of -84.2 % over the past year, with a market capitalization of USD 7.13M.

Mangoceuticals, Inc. recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

Mangoceuticals, Inc. key figures

Previous close

USD 0.33 (2026-10-14)

1-year change

-84.2 %

Market cap

USD 7.13M

Enterprise value

USD 6.97M

P/E ratio (trailing)

-0.36

P/E ratio (forward)

n/a

EPS (trailing)

-0.89

EPS (forward)

n/a

PEG ratio

n/a

Price to book

0.46

Revenue growth

-59.1 %

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

0.91

Employees

3

Analyst consensus (third-party)

none

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About Mangoceuticals, Inc.

Mangoceuticals, Inc. engages in the development, marketing, and sale of various men's wellness products and services through a telemedicine platform in the United States. The company offers erectile dysfunction products under the Mango brand; hair loss products under the Grow brand; hormone balance and therapy products under the Mojo brand; and weight loss products under the Slim brand. It also provides oral testosterone undecanoate to treat low testosterone in men and as a form of testosterone replacement therapy under the Prime brand; and access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations. In addition, the company markets and sells its products online through its website www.MangoRX.com. The company was incorporated in 2021 and is headquartered in Dallas, Texas. Mangoceuticals, Inc. operates as a subsidiary of Cohen Enterprises, Inc.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for Mangoceuticals, Inc. and compare it with other stocks.